Hongfeng Deng

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi request reprint Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors
    Hongfeng Deng
    GlaxoSmithKline, Platform Technology and Science Molecular Discovery Research, ELT Boston, 830 Winter Street, Waltham, MA 02451, USA
    Expert Opin Drug Discov 5:961-93. 2010
  2. doi request reprint Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT)
    Hongfeng Deng
    ELT Boston, Platform Technology and Science, GlaxoSmithKline, Waltham, Massachusetts, United States
    J Med Chem 55:7061-79. 2012

Detail Information

Publications2

  1. ncbi request reprint Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors
    Hongfeng Deng
    GlaxoSmithKline, Platform Technology and Science Molecular Discovery Research, ELT Boston, 830 Winter Street, Waltham, MA 02451, USA
    Expert Opin Drug Discov 5:961-93. 2010
    ..With the entry of several compounds into clinical trials, FAAH inhibitor-based medicines are on the horizon...
  2. doi request reprint Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT)
    Hongfeng Deng
    ELT Boston, Platform Technology and Science, GlaxoSmithKline, Waltham, Massachusetts, United States
    J Med Chem 55:7061-79. 2012
    ..This study provides the first small molecule evidence for the critical role of ADAMTS-5 in human cartilage degradation...